Sleep Duration Required to Restore Performance During Chronic Sleep Restriction

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Elizabeth B. Klerman, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT01581125
First received: March 22, 2012
Last updated: July 15, 2016
Last verified: July 2016

March 22, 2012
July 15, 2016
April 2012
June 2016   (final data collection date for primary outcome measure)
Psychomotor Vigilance Task (PVT) performance [ Time Frame: PVT during waking for arms 1 and 2 during the 32-day inpatient portion of the protocol ] [ Designated as safety issue: No ]
PVT metrics are reaction time. It is measured when the participants are awake during the inpatient portion of the protocol.
Same as current
Complete list of historical versions of study NCT01581125 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Sleep Duration Required to Restore Performance During Chronic Sleep Restriction
Sleep Duration Required to Restore Performance During Chronic Sleep Restriction
The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase.
The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase. Inpatient sleep and performance data will be collected from healthy volunteers.
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
  • Sleep
  • Sleep Deprivation
  • Insufficient Sleep Syndrome
  • Behavioral: Sleep:wake 1
    Sleep and Wake durations for arm 1
  • Behavioral: Sleep:wake 2
    Sleep and Wake durations for arm2
  • Experimental: Sleep:wake 2
    Sleep and wake durations for arm 2 for inpatient portion of protocol. .There are a variety of sleep and wake durations during the protocol; some of these are longer and some are shorter and some are the same as in arm 1.
    Intervention: Behavioral: Sleep:wake 2
  • Experimental: Sleep:wake 1
    Sleep and wake durations for arm 1 of the inpatient portion of the protocol. There are a variety of sleep and wake durations during the protocol; some of these are longer and some are shorter and some are the same as in arm 2.
    Intervention: Behavioral: Sleep:wake 1
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
19
June 2016
June 2016   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy

Exclusion Criteria:

  • Prescription medications
Both
18 Years to 35 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01581125
NIH R01 HL114088-01
No
Not Provided
Not Provided
Elizabeth B. Klerman, Brigham and Women's Hospital
Brigham and Women's Hospital
Not Provided
Principal Investigator: Elizabeth B Klerman, MD PhD Brigham and Women's Hospital
Brigham and Women's Hospital
July 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP